Picture of Accenture logo

ACN Accenture News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedLarge CapContrarian

Accenture PLC reports results for the quarter ended May 31 - Earnings Summary

Accenture PLC reports results for the quarter ended May 31 - Earnings Summary
  • Accenture PLC ACN.N reported quarterly adjusted earnings of $3.80​​ per share for the quarter ended May 31, higher than the same quarter last year, when the company reported EPS of $3.49. The mean expectation of twenty analysts for the quarter was for earnings of $3.71 per share. Wall Street expected results to range from $3.60 to $3.79 per share.

  • Revenue rose 5.6% to $18.72 billion from a year ago; analysts expected $18.75 billion.

  • Accenture PLC's reported EPS for the quarter was $3.80​.

  • The company reported quarterly net income of $2.34 billion.

  • Accenture PLC shares had fallen by 21.3% this quarter and lost 41.9% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 0.6% in the last three months.​

  • In the last 30 days, nine analysts negatively revised earnings estimates

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 18 "strong buy" or "buy," 11 "hold" and no "sell" or "strong sell." The average consensus recommendation for the it services & consulting peer group is also "buy"

  • Wall Street's median 12-month price target for Accenture PLC is $237.00, about 34.2% above its last closing price of $156.01

This summary was machine generated from LSEG data June 18 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

May. 31 2026

3.71

3.80

Beat

Feb. 28 2026

2.84

2.93

Beat

Nov. 30 2025

3.74

3.94

Beat

Aug. 31 2025

2.96

3.03

Beat

Recent news on Accenture

See all news